Manufacturer
M/S Gland Pharma Limited
Contents
Heparin Sodium
Indication
Prophylaxis of re-occlusion of the coronary arteries following thrombolytic therapy in myocardial infarction, Peripheral arterial embolism, Unstable angina, Venous thromboembolism, Prophylaxis of postoperative venous thromboembolism.
Instruction
Administer via IV/Subcutaneous injection
Drug interaction
Enhanced anticoagulant effect w/ other drugs affecting platelet function or the coagulation system (e.g. platelet aggregation inhibitors, thrombolytic agents, salicylates, NSAIDs, vit K antagonists, dextrans, activated protein C). Decreased anticoagulant effect w/ gyceryl trinitrate infusion. Increased risk of hyperkalaemia w/ ACE inhibitors or angiotensin II antagonists.
Malaysia
